➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
AstraZeneca
Merck
McKinsey

Last Updated: April 17, 2021

DrugPatentWatch Database Preview

Nesher Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NESHER PHARMS, and what generic and branded alternatives to NESHER PHARMS drugs are available?

NESHER PHARMS has thirty-seven approved drugs.

There is one tentative approval on NESHER PHARMS drugs.

Summary for Nesher Pharms
US Patents:0
Tradenames:25
Ingredients:23
NDAs:37

Drugs and US Patents for Nesher Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 040365-001 Oct 31, 2002 DISCN No No   Start Trial   Start Trial
Nesher Pharms DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 206588-002 Mar 28, 2016 AA RX No No   Start Trial   Start Trial
Nesher Pharms MORPHINE SULFATE morphine sulfate TABLET, EXTENDED RELEASE;ORAL 077855-002 Sep 27, 2007 DISCN No No   Start Trial   Start Trial
Nesher Pharms DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 207340-007 Oct 31, 2017 AB RX No No   Start Trial   Start Trial
Nesher Pharms POTASSIUM CHLORIDE potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 070980-001 Feb 17, 1987 DISCN No No   Start Trial   Start Trial
Nesher Pharms DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076563-005 Sep 12, 2006 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Nesher Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Nesher Pharms MICRO-K potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-001 Approved Prior to Jan 1, 1982 4,259,315   Start Trial
Nesher Pharms MICRO-K 10 potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-002 May 14, 1984 4,259,315   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
Baxter
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.